Neonatal Abstinence Syndrome

1761 Words8 Pages
Neonatal Abstinence Syndrome (NAS) is a growing concern within the United States. This paper discusses what NAS is and the effects it has on the newborn infant. If first discusses the incidence of NAS as regard to maternal age, race, and ethnicity. It explains the types of drugs most commonly associated with Neonatal Abstinence Syndrome. However, I have excluded alcohol from this paper because it results in Fetal Alcohol Syndrome. This paper will then explain the types of physical symptoms associated with NAS for the full-term and premature infant. It discusses the different classes of drugs and the unique symptoms newborns experience with each. Furthermore, it discusses the long-term cognitive and behavioral effects that newborns can experience as they grow. In addition, this paper discusses how Neonatal Abstinence Syndrome is diagnosed and the how the Finnegan neonatal scoring system is used to help physicians determine the severity of NAS in each newborn. Lastly, this paper explains the treatment for NAS and the important roles of the nurse when caring for a newborn with Neonatal Abstinence Syndrome. Neonatal Abstinence Syndrome (NAS) is a group of problems a newborn experiences when exposed to addictive drugs that the mother consumes during pregnancy. NAS is a growing concern in the United States and can have significant adverse effects on newborns. Shortly after birth the infant can display many physical symptoms of withdrawal. In addition, substance abuse during pregnancy can cause premature birth, low birth weight, seizures, birth defects, Sudden Infant Death Syndrome (SIDS), and possible long-term cognitive and behavioral problems. The 2010 results from the National Survey on Drug Use and Health: Summary o... ... middle of paper ... ...Midwifery, 16(4), 220-223 Neonatal abstinence syndrome. (2010). Retrieved from Neonatal abstinence syndrome. (2011). Retrieved from Neonatal abstinence syndrome. (2012a). Retrieved from Neonatal abstinence syndrome. (2012b). Retrieved from Results from the 2010 national survey on drug use and health: summary of national findings. (2011). Retrieved from Zimmermann-Baer, U., Nötzli, U., Rentsch, K., & Bucher, H. U. (2010). Finnegan neonatal abstinence scoring system: normal values for first 3 days and weeks 5-6 in non-addicted infants. Addiction, 105(3), 524-528.
Open Document